Enhancer Screening via rAAV Mini-Circle Vectors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening enhancers across cell types are inefficient and face challenges such as delivering enhancer libraries to sufficient cell populations, scoring specificity across different cell types, and avoiding enhancer interference.
Innovation Solution
The development of a vector containing a polynucleotide with a cis regulatory element, promoter sequence, barcode, and invertible spacer sequence, which is stabilized by mini-circle formation and administered via recombinant adeno-associated virus (rAAV) particles to enable high-throughput screening of enhancers for cell type-specific expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If large pools of enhancers are screened across multiple cell types, then the comprehensiveness of enhancer characterization is improved, but enhancer interference between co-administered enhancers increases
Solution Approach 1:
The patent segments the enhancer library into individually packaged AAV vectors, each containing a single enhancer sequence. This physical separation prevents interference between enhancers while maintaining the ability to screen large pools through parallel administration of multiple isolated vectors to different cell populations.
Solution Approach 2:
The patent introduces a barcode sequence as an intermediary marker linked to each enhancer. This barcode serves as a detectable signal that allows identification and scoring of enhancer activity in specific cell types without the enhancers interfering with each other, enabling high-throughput screening through sequencing analysis.
2Measurement precision
If enhancer libraries are delivered to large cell populations, then the recovery of quantitative expression information is improved, but the complexity of delivering and scoring across diverse cell types increases
Solution Approach 1:
The patent creates a universal screening platform where AAV vectors packaged with enhancer libraries can be delivered to diverse cell types through a single administration route. The same barcode-linked enhancer construction works across multiple cell types, eliminating the need for separate delivery and scoring systems for each cell type.
Solution Approach 2:
The patent replaces complex mechanical or manual scoring methods with molecular sequencing analysis. By using barcode sequences that can be read through next-generation sequencing, the system automates the scoring process across diverse cell types, reducing manual intervention and system complexity while maintaining precise quantitative measurement.
3Measurement precision
If single-cell RNA sequencing is used to assess enhancers, then cell type-specific assessment is enabled, but sparse RNA capture and limited library size reduce effectiveness
Solution Approach 1:
The patent uses barcode sequences as copies or proxies for enhancer activity. Instead of directly sequencing rare RNA transcripts from individual cells, the system uses the barcode sequence linked to the enhancer as a detectable copy that can be amplified and sequenced more reliably, overcoming the sparsity problem while maintaining cell type-specific resolution.
Solution Approach 2:
The patent changes the detection parameter from direct RNA transcript sequencing to barcode sequence sequencing. This parameter change allows for more robust detection across larger cell populations and larger enhancer libraries, as barcodes can be amplified more efficiently than rare transcripts, thereby improving both library size capacity and cell type-specific assessment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for effective screening of large pools of enhancers across cell types, minimizing interference and achieving near single-cell specificity in expression analysis.
Implementation Method 1
Contacting the polynucleotide with a recombinase forms a mini-circle and stabilizes mRNA transcribed from the polynucleotide in a cell
Data Source
AI summary
The invention provides compositions and methods that are useful for screening gene regulatory elements for cell type-specific expression in vivo.